Scarica l'app Stockscreener
0.6299
4.08%
-0.0268
Dopo l'orario di chiusura:
.59
-0.0399
-6.33%
Hcw Biologics Inc Borsa (HCWB) Ultime notizie
HCW Biologics (NASDAQ: HCWB) seeks warrant approvals at Apr 27 meeting - Stock Titan
HCWB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HCW Biologics regains compliance with all continued listing rules for Nasdaq per Nasdaq determination letter - marketscreener.com
HCW Biologics Regains Nasdaq Listing Compliance, Faces Ongoing Oversight - TipRanks
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter - The Manila Times
HCW Biologics (NASDAQ: HCWB) back in full Nasdaq compliance - Stock Titan
HCW Biologics : February 2026 - marketscreener.com
EV Market: Is HCW Biologics Inc gaining market shareJuly 2025 Sector Moves & Stock Timing and Entry Methods - baoquankhu1.vn
EDGAR Filing Documents for 0000950170-24-127198 - SEC.gov
HCW Biologics Completes Follow-On Offering to Fund Pipeline - TipRanks
HCW Biologics Prices $1.5 Million Follow-On Offering of 2.48M Units at $0.6055 - TradingView
HCW Biologics Prices $1.5 Million Unit Offering - marketscreener.com
HCW Biologics lines up $1.5M, cuts warrant price to $0.6055 - Stock Titan
HCW Biologics Announces Follow-On Offering Pricing - Intellectia AI
HCW Biologics Inc. Announces Pricing of Follow-On Offering to Fund Immunotherapy Development - Quiver Quantitative
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - marketscreener.com
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewswire Inc.
Chipmakers Recap: Will HCW Biologics Inc outperform tech stocksJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
HCWB PE Ratio & Valuation, Is HCWB Overvalued - Intellectia AI
HCW Biologics Licenses TRBC Asset to China JV Trimmune - TipRanks
HCW Biologics enters $7 million licensing deal with China-based Trimmune - Investing.com Nigeria
HCW Biologics and WY Biotech announce closing of first round of financing for newly formed joint venture Trimmune - marketscreener.com
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune - Investing News Network
Hcw Biologics And Wy Biotech Announce Closing Of First Round Of Financing For Newly Formed Joint Venture Trimmune - TradingView
Inside HCW Biologics’ $7M deal to test a new cancer drug in China - Stock Titan
Is HCW Biologics Inc. forming a breakout patternJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - mfd.ru
What is HCW Biologics Inc.’s book value per shareWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
Downgrade Watch: How sensitive is HCW Biologics Inc to inflationFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn
Market Leaders: Can HCW Biologics Inc. stock double in the next yearJuly 2025 PreEarnings & Low Volatility Stock Suggestions - baoquankhu1.vn
RSI Check: What is the earnings history of HCW Biologics IncJuly 2025 Earnings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Risk Off: Can HCW Biologics Inc stock double in the next yearPortfolio Value Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
HCW Biologics restructures obligations to regain Nasdaq compliance - MSN
US Stocks Recap: Is HCW Biologics Inc. forming a breakout patternJuly 2025 Highlights & Verified Momentum Watchlists - baoquankhu1.vn
Is HCW Biologics Inc. stock recession proofEarnings Recap Summary & Weekly Sector Rotation Insights - Улправда
How analysts rate HCW Biologics Inc. stock todayQuarterly Trade Summary & AI Enhanced Execution Alerts - ulpravda.ru
Will HCW Biologics Inc. stock attract ESG investorsJuly 2025 Spike Watch & Safe Capital Preservation Plans - Улправда
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - The Globe and Mail
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com Nigeria
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa
HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets
Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn
HCW Biologics Granted Nasdaq Compliance Extension - MSN
Aug Analyst Calls: Is HCW Biologics Inc stock recession proofGDP Growth & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - Bộ Nội Vụ
HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World
Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World
HCW Biologics Earnings Notes - Trefis
Is HCW Biologics Inc. stock gaining market shareJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Is HCW Biologics Inc. stock attractive for growth ETFsMarket Performance Report & Low Drawdown Investment Ideas - Улправда
Is HCW Biologics Inc. stock a buy in volatile markets2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
Can HCW Biologics Inc. stock deliver consistent earnings growthMarket Activity Summary & AI Forecasted Entry/Exit Points - DonanımHaber
Can HCW Biologics Inc. stock deliver strong Q4 earningsMarket Activity Report & Community Trade Idea Sharing - bolumsonucanavari.com
HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):